The Future of MS Management: Novel Agents and Clinical Approaches

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/c9/f7/ff/c9f7ff15-9147-25c6-3f52-5ec0e7937d1c/mza_15582707485019730366.jpg/600x600bb.jpg

NeuroFrontiers

ReachMD

186 episodes

1 month ago

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health. So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

Science

Medicine

RSS

All content for NeuroFrontiers is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

The Future of MS Management: Novel Agents and Clinical Approaches

NeuroFrontiers

3 months ago

The Future of MS Management: Novel Agents and Clinical Approaches

Guest: Marisa McGinley, DO

The multiple sclerosis (MS) treatment landscape is rapidly evolving, with novel approaches on the horizon that may transform care for progressive patients. Explore the latest phase 3 data on BTK inhibitors like tolebrutinib and gain insights into ongoing CAR T-cell and remyelination research, including the BEAT-MS trial, with Dr. Marisa McGinley, a neurologist at the Cleveland Clinic.